Navigation Links
Federal Grant of $275,000 Funds Study of Young Adult Attitudes Toward Flavored Tobacco
Date:9/17/2013

Atlanta, Georgia (PRWEB) September 18, 2013

Dr. Kymberle Sterling, assistant professor in the School of Public Health at Georgia State University, has received a two-year, $275,000 grant from the National Cancer Institute to study how young adult smokers perceive the risk of smoking flavored little cigars and cigarillos (LCCs), which the Food and Drug Administration (FDA) does not regulate.

The health risks associated with smoking flavored LCCs are very similar to those from cigarettes. They cause nicotine dependence and cancer.

The grant will allow Sterling, with investigators at the University of Hawaii-Manoa Cancer Center and the University of Maryland College Park School of Public Health, to develop a prognostic tool that identifies LCC risk perceptions and predicts susceptibility to smoke LCCs among young adult cigarette smokers.

Use of flavored LCCs is growing at an alarming rate among young adult cigarette smokers, especially those from ethnic minority groups. Preliminary data show young adult smokers enjoy the taste and smell of LCCs, consider smoking LCCs with peers as “cool” and feel they can quit LCCs anytime. Early indicators suggest these smokers believe LCCs are less harmful than cigarettes.

“Dr. Sterling’s research, which adds to a growing body of tobacco expertise at Georgia State, will help inform how we respond to one of the latest threats in the battle against tobacco,” noted School of Public Health dean and lead author of the ”Tobacco Atlas,” Michael P. Eriksen. “It is expected to help scientists and policy makers understand the ways in which young adult cigarette smokers think about and respond to risks related to flavored LCCs.”

The 2010 Family Smoking Prevention and Tobacco Control Act authorized the FDA to regulate the manufacture, distribution and marketing of flavored cigarettes, with the exception of menthol cigarettes, but did not grant regulatory authority over flavored little cigars and cigarillos (LCCs). LCCs are tobacco products inhaled like cigarettes and similar in size, shape, filtering and tobacco pH.

The tobacco control community knows very little about how young adult cigarette smokers form risk perceptions of LCCs. Researchers believe understanding young adult smokers’ attitudes is vital to effective regulatory policy as well as prevention methods.

Read the full story at http://www.prweb.com/releases/2013/9/prweb11133291.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Federal grant of $275,000 funds study of young adult attitudes toward flavored tobacco
2. DrugRisk Update: Byetta Lawsuits Headed to Special Federal Court
3. DePuy ASR Hip Replacement Lawsuit Trial: Jury Selection in First Federal Trial of DePuy ASR Hip Recall Lawsuit to Begin on September 24th, Wright & Schulte LLC Reports
4. Pradaxa Lawsuit News: Bernstein Liebhard LLP Reports on Latest Status Conference in Federal Pradaxa Bleeding Litigation
5. Biomet Hip Replacement News: Federal Multidistrict Litigation for Biomet Hip Lawsuits to Hold Status Conference, Bernstein Liebhard LLP Reports
6. Actos Lawsuit News: Bernstein Liebhard LLP Notes Scheduling of Next Status Conference in Federal Actos Bladder Cancer Litigation
7. Transvaginal Mesh Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Upcoming Joint Conference for Federal Vaginal Mesh Lawsuits
8. DePuy Pinnacle Lawsuits: Bernstein Liebhard LLP Reports on Latest Developments in Federal Pinnacle Hip Lawsuits
9. Pradaxa Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Issuance of New Case Management Order in Federal Pradaxa Bleeding Litigation
10. Biomet Hip Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Issuance of New Case Management Order in Federal Biomet Hip Replacement Litigation
11. DrugRisk Update: Januvia Lawsuits Alleging Cancer Headed to Federal Court
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/13/2017)... ... October 13, 2017 , ... Ellevate Network, the leading ... to advocate for action towards gender equality at their inaugural Summit in New York ... globe, and reached a social audience of over 3 million. To watch the Mobilize ...
(Date:10/13/2017)... ... 2017 , ... Yisrayl Hawkins, Pastor and Overseer at The House of Yahweh, ... and least understood books in the Holy Scriptures, Revelation. The Book of Revelation paints ... for centuries. Many have tossed it off as mere rubbish, but Yisrayl Hawkins says ...
(Date:10/13/2017)... ... October 13, 2017 , ... ... Software Development, has been awarded a contract by the Center for Medicare and ... aims to accelerate the enterprise use of Agile methodologies in a consistent and ...
(Date:10/13/2017)... ... ... “America On The Brink”: the Christian history of the United States and ... of published author, William Nowers. Captain Nowers and his wife, Millie, have six ... years in the Navy. Following his career as a naval aviator and carrier ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and San Francisco ... using cutting-edge Oventus O2Vent technology. As many as 18 million Americans are estimated ... in breathing. Oral appliances can offer significant relief to about 75 percent of ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... , Sept. 28, 2017 Cohen Veterans ... advance the use of wearable and home sensors for ... disorders. Early Signal Foundation, a nonprofit organization focused on ... will provide an affordable analytical system to record and ... ...
(Date:9/27/2017)... , Sept. 27, 2017  DarioHealth Corp. (NASDAQ: DRIO), a leading global ... that its MyDario product is expected to appear on The Dr. Oz ... Dr. Oz Show airs in your area: http://www.doctoroz.com/page/where-watch-dr-oz-show ... The nine-time Emmy award-winning, The Dr. Oz Show kicked ... The segment features ...
(Date:9/25/2017)... 25, 2017  EpiVax, Inc., a leader in ... immune-engineering today announced the launch of EpiVax Oncology ... personalized therapeutic cancer vaccines. EpiVax has provided $500,000 ... to enabling technologies to the new precision immunotherapy ... EpiVax Oncology as Chief Executive Officer. Gad brings ...
Breaking Medicine Technology: